Vertex Pharmaceuticals (VRTX)

Net Change in Cash

$649.20M

Quarterly · Period ending: · USD

VRTX logo

VRTX Net Change in Cash

Latest reported$649.20M
VRTX Quarterly Net Change in Cash ($26.00M → $649.20M)
High-resolution chart · PNG

VRTX net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
649,200,000
417,100,000
140,000,000
-34,200,000
296,600,000
113,200,000
-675,900,000
657,100,000
-4,578,400,000
-1,202,900,000
-744,300,000
963,200,000
857,800,000
-1,216,400,000
1,335,000,000
472,900,000
1,100,100,000
803,900,000
519,887,000
209,145,000
-241,839,000
324,062,000
627,860,000
525,285,000
1,233,736,000
481,283,000
-283,910,000
102,945,000
400,114,000
243,279,000
171,202,000
332,983,000
148,340,000
338,202,000
280,446,000
161,836,000
219,451,000
-180,266,000
464,253,000
113,826,000
1,621,000
-110,523,000
-41,482,000
-114,293,000
205,664,000
39,620,000
-93,304,000
298,005,000
-3,487,000
-145,254,000
-13,882,000
51,934,000
152,148,000
-110,308,000
52,521,000
-17,175,000
186,138,000
-207,397,000
-67,225,000
84,350,000
11,659,000
203,339,000
-326,704,000
232,293,000
-58,939,000
-50,111,000
-112,475,000
150,184,000
-193,250,000
213,084,000
-153,761,000
-6,756,000
58,936,000
135,033,000
101,684,000
85,261,000
-185,610,000
141,157,000
-270,260,000
442,001,000
-40,397,000
3,782,000
-23,574,000
-93,076,000
157,324,000
-17,635,000
17,969,000
-26,655,000
10,685,000
-45,152,000
20,710,000
-55,961,000
-47,363,000
72,675,000
4,504,000
-21,674,000
-50,961,000
-12,976,000
-6,746,000
27,424,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.